GlassScriptPhysician profile
Mario Fatigati
NPI 1083677215
$1,010.36
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $118 · 2021: $35.29.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $204.43 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $150.97 | 2019-2020 | |
| Lilly USA, LLC | $106.50 | 2019-2020 | |
| Allergan, INC. | $65.27 | 2019 | |
| Daiichi Sankyo INC. | $64.02 | 2019 | |
| Novo Nordisk INC | $58.53 | 2019 | |
| Pfizer INC. | $49.15 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $47.81 | 2019 | |
| Abbvie INC. | $44.43 | 2019-2021 | |
| Abbott Laboratories | $43.99 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $42.22 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.64 | 2019 | |
| Sanofi Pasteur INC. | $20.30 | 2019 | |
| Biogen, INC. | $19.74 | 2019 | |
| Amgen INC. | $15.40 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $14.00 | 2019 | |
| Insulet Corporation | $13.81 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.80 | 2019 | |
| Philips North America LLC | $11.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Fatigati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.